300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Guernsey
Cameroon
Colombia
Costa Rica
China
Armenia
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Canada
Germany
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Friend Investment Partners, VC Fund

Friend Investment Partners

VC Fund

Seongnam, South Korea

Friend Investment Partners is an investment firm,

Total investments:
20
Last investment:
Lead investor:
5%

Last updated:

Industries Friend Investment Partners invests in

MedicalHealth CareBiotechnologyManufacturingInformation Technology

Stages Friend Investment Partners invests in

Series ASeries BSeries CVenture - Series UnknownFunding Round

Countries Friend Investment Partners invests in

South Korea

Round sizes

Series A $435k–$10MSeries B $3.6M–$19MSeries C $20M–$31M

Round size

Series A
$435k–$10M
Series B
$3.6M–$19M
Series C
$20M–$31M

Investment Focus

Industry

  • Medical 5 (25%)
  • Health Care 4 (20%)
  • Biotechnology 4 (20%)
  • Manufacturing 4 (20%)
  • Information Technology 4 (20%)
See all 52 industries →

Stage

  • Series A 8 (40%)
  • Series B 6 (30%)
  • Series C 2 (10%)
  • Venture - Series Unknown 2 (10%)
  • Funding Round 1 (5%)
See all 6 stages →

Investments

CompanyDescriptionRoundLinks
Founded in Seoul, South Korea, CloudHospital is a robust online platform helping patients around the world find the best providers for their needs regardless of where they are located. We are an experienced team from around the globe with ample experience in the fields of web technology, medical practice, and finance. Our mission is simple: to makeit easier for everyone to find the best medical solutions anywhere in the world.By investing in technology that takes the complexities out of world-wide medical services, icloudhospital.com can seamlessly connect millions of patients around the world to excellent medical services, both from the most demanding surgeries to the most accurate health checkups as well as the world’s most advanced cosmetic procedures. As one of the world’s most well integrated medical concierge services firm, icloudhospital.com enables hospitals and clinics around the world reach their global audience efficiently.Our services, which are accessible through icloudhospital.com is available in English, Chinese and Russian and offers the best medical hospitals and clinics, including the best respected doctors in their field of expertise. For all your medical care needs, icloudhospital.com makes it easy and supports you with 24/7 customer support. Series A / Nov 17, 2025
While the software industry is booming and demand for people with software skills is greater than ever, the education just isn't there. Codeit tackles the education problem with three simple solutions: (1) better content, (2) better platform, (3) for an affordable price. Codeit provides an interactive online platform to teach today'smost in-demand skills—programming and data science. We have had over 100,000 students, the vast majority of whom decided a change in career. We certainly are proud of our achievements so far in better equipping the world with digital skills. However, Codeit exists to serve a bigger purpose—to help people "learn to love learning". Our take on education is that it's much more than about simply imparting knowledge. It's about bringing out the innate human affinity towards learning. We began our journey in South Korea teaching programming and data science. Our next step is to expand globally, and to extend our offerings to include topics like design, marketing, and product management. If any of this interests you, please leave us a message at: recruit@codeit.kr $7M / Venture - Series Unknown / Sep 26, 2025
CUBIG protects personal data from hyper-scale AI via privacy-preserving synthetic data by enabling data owners' pseudonymization and data de-identification data may be kept and shared safely. $434.9K / Series A / Aug 13, 2025
RideFlux is a self-driving software company for safe and reliable autonomous transporation service. Since our foundation in 2018, we hope for a better world where everyone can be safer and more comfortable while moving with our self-driving cars and software. We believe in the potential that self-driving technology embraces, how driving canbecome an innovative experience not a mere stress, which inspires us to build up its future with every step on our way.Our headquarter is located in Jeju island, one of the best test-beds in the world for developing reliable AD software technologies. It has a variety of road environments and various weather conditions across the island (1850 square kilometers), and significantly high demands for mobility service (16 million visitors a year without bring own vehicles). We are strategically located for technology enhancement for reliable urban autonomy. For the Safety, Beyond the Safety. $18.9M / Series B / Oct 31, 2024
Hyundai M Systems is the developer of safety equipment intended for the construction industry. The company supplies safety systems using radar, cameras, monitors, and controllers that are installed on excavators, wheel loaders, haulers, and compactors produced by these manufacturers, enabling businesses to minimize work site risks. $3.6M / Series B / Jul 01, 2024
Soft Berry is an electric vehicle charging platform. $3.6M / Series A / Mar 21, 2024
KB-Element is a graphene development and production company that also turns graphene into intermediate items and novel materials. $5.2M / Convertible Note / Oct 11, 2023
​Seers Technology is a digital healthcare solution provider that offers remote patient monitoring systems, including the mobiCARE™ platform, which utilizes wearable biosensors and AI algorithms to collect and analyze vital signs such as ECG, heart rate, respiration, and temperature. Seers Technology's products are CE and FDA certified and havebeen adopted by over 400 hospitals worldwide, including participation in telehealth pilot projects across the USA, Europe, and Southeast Asia. Their offerings also encompass patient monitoring services like thynC™, medical AI solutions, and advanced medical materials. $19.6M / Series C / Jun 24, 2022
Genecker develops genetic analysis technologies aimed at enabling the early detection and personalized management of cancer and genetic disorders. The company offers genome analysis services for oncology, prenatal screening, rare diseases, and individual health assessments, providing healthcare professionals and individuals with accurate andcost-effective diagnostic insights to support informed clinical decision-making. $6.6M / Series B / Apr 01, 2022
ANLBIO is a researcher and developer of adeno-associated virus-based gene therapy products. $10.4M / Series A / Feb 17, 2022
See all 20 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Guernsey
Cameroon
Colombia
Costa Rica
China
Armenia
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Moldova
Seychelles
Paraguay
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Canada
Germany
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Friend Investment Partners invest in?

Friend Investment Partners invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 20 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Friend Investment Partners invest in?

Friend Investment Partners typically joins rounds of $435k–$10M at Series A, $3.6M–$19M at Series B and $20M–$31M at Series C. These are whole funding-round sizes, not Friend Investment Partners's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Friend Investment Partners took part in.

When did Friend Investment Partners last invest?

The most recent investment recorded for Friend Investment Partners closed in Nov 2025. Shizune tracks 20 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Friend Investment Partners Friend Investment Partners Find emails